Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; Evaluation of possible linkage

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 111-117

  Ahbab, Süleyman ^a   Ataoǧlu, Hayriye Esra ^a   Tuna, Mazhar ^a   Karasulu, Levent ^b   Çetin, Faik ^a   Temiz, Levent Ümit ^a   Yenigün, Mustafa ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Yedikule Education and Research Hospital   (Turkey)

Author keywords

Apnea hypopnea index; Metabolic syndrome; Neck circumference; Obstructive sleep apnea syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; NECK CIRCUMFERENCE; OXYGEN DESATURATION; POLYSOMNOGRAPHY; RESPIRATORY AIRFLOW; RISK FACTOR; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84876835338     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883776     Document Type: Article

References (35)

1. Angelico F. Ben M. Augeletti T et al: Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting. Eur J Int Med. 2010; 21: 191-95
2. Zirlik S, Hauck T, Fuchs F et al: Leptin. Obestatin and Apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit. 2011; 17(3): CR159-CR164
3. Papanas N. Steiropoulos P. Nena E et al: Predictors of obstructive sleep apnoea in males with metabolic syndrome. Vasc Health Risk Manag. 2010; 6: 281-286
4. Korostovtseva LS, Sviryaev Y V, Zvartau NE et al: Prognosis and cardiovascular morbidity and mortality in prospective study of hypertensive patients with obstructive sleep apnea syndrome in St Petersburg. Russia. Med Sci Monit. 2011; 17(3): CR146-CR153
5. Sipilä K. Moilanen L. Nieminen T et al: Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis. 2009; 204(1): 276-81
6. Peppard PE. Young T. Patla M. Skatrud J: Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med. 2000; 342(19): 1378-84
7. Peled N. Kassirer M. Shitrit D et al: The association of OSA with insulin resistance. inflammation and the metabolic syndrome. Resp Med. 2007; 101: 1696-701
8. Barcelò A, Barbé F, de la Pegna M et al: Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax. 2008; 63: 946-50
9. Makino S. Handa H Suzukawa K et al: Obstructive sleep apnoea syndrome. plasma adiponectin levels and insulin resistance. Clin Endocrinol. 2006; 64(1): 12-19
10. Harsh IA, Hahn EG, Konturek PC: Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit. 2005; 11(3): RA70-RA75
11. Ip MS. Lam B. Ng MM et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002; 165(5): 562-63
12. Kono M. Tatsumi K. Saibara T et al: Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007; 131(5): 1387-92
13. Volna J, Kemlink D, Kalousova M et al: Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit. 2011; 17(9): CR491-CR497
14. Mishra P. Nugent C. Afendy A et al: Apnoeic-hypopnoeic episodes duringobstructive sleep apnoea are associated with histological nonalcoholic ste-atohepatitis. Liver Int. 2008; 28(8); 1080-86
15. Hoffstein V. Szalai JP: Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep. 1993; 16(2): 18-22
16. Strohl KP. Redline S: Recognition of obstructive sleep apnea. Am J Respir Crit Care Med. 1996; 154(2): 279-89
17. Young T. Peppard P. Palta M et al: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997; 157(15): 1746-52
18. Carmelli D. Swan GE. Bliwise DL: Relationship of 30-year changes in obesity to sleep-disordered breathing in the Western Collaborative Group Study. Obes Res. 2000; 8(9): 632-37
19. Reaven G: Metabolic syndrome: Pathophysiology and implications for management of cardiovascular disease. Circulation. 2002; 106: 286-88
20. Muniyappa R. Lee S. Chen H et al: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages. limitations. and appropriate usage. Am J Physiol Endocrinol Metab. 2008; 294: E15-26
21. Bouloukaki I. Kapsimalis F. Mermigkis C et al: Prediction of obstructive sleep apnea syndrome in a large Greek population. Sleep Breath. 2011; 15(4): 657-64
22. Gami AS. Somers VK: Obstructive sleep apnoea. metabolic syndrome and cardiovascular outcomes. Eur Heart J. 2004; 25: 709-11
23. Papadavid E. Vlami K. Dalamaga M: Sleep apnea as a comorbidity in obese psoriasis patients: a cross-sectional study. Do psoriasis characteristics and metabolic parameters play a role? J Eur Acad Dermatol Venerol. 2012; DOI: 10.1111/j.1468-3083.2012.04580.x
24. Dalamaga M, Papadavid E, Vlami K: Unmasking the Janus face of the association between psoriasis. metabolic syndrome and obstructive sleep apnea. Sleep Breath. 2012; DOI 10.1007/s11325-012-0749-4
25. Coughlin SR. Mawdsley L. Mugarza et al: Obstructive sleep apnoea is independent association with an increased prevalence of metabolic syndrome. Eur Heart J. 2004; 25: 735-41
26. Redline S. Storfer-Isser A. Rosen CL et al: Association between metabolic syndrome and sleep disordered breathing in adolescents. Am J Respir Crit Care Med. 2007; 176(4): 401-8
27. Tufik S. Silva RS. Taddei JA et al: Obstructive sleep apnoea syndrome in the sao paulo epidemiolgic sleep study. Sleep Med. 2010; 11: 441-46
28. Ucok K. Aycicek A. Sezer M et al: Resting metabolic rate and anthropometric measurements in male sleep apnea patients. Intern Med. 2011; 50(8): 833-38
29. Soylu AC. Levent E. Sariman N et al: Obstructive sleep apnea syndrome and anthropometric obesity indexes. Sleep Breath 2012;16(4): 1151-58
30. Hla KM. Young TB. Bidwell T et al: Sleep apnoea and hypertention: A poplation based study. Ann Intern Med. 1994; 120(5): 382-88
31. Lavie P. Herer P. Hoffstein V: Obstructive sleep apnoea syndrome as a risk factor for hypertention: population study. BMJ. 2000; 320: 479-82
32. Onat A. Hergenc G. Yüksel H et al: Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnoea syndrome beyond waist circumference. Clin Nutr. 2009; 28: 46-51
33. Paris JM. Somers VK: Obstructive sleep apnoea and cardiovascular disease. Mayo Clin Proc. 2004; 79: 1036-46
34. Nieto FJ. Young TB. Lind BK et al: Association of sleep disordered breathing sleep apnoea and hypertention in large community based study. JAMA. 2000; 283: 1829-36
35. Newman AB. Nieto FJ. Guidry U et al: Relationship of sleep disordered breathing to cardiovascular risk factors. The Sleep Heart Health Study. Am J Epidemiol. 2001; 154: 50-59